1. Chindaprasirt J, Wongtirawit N, Limpawattana P, et al. Perception of a “good death” in Thai patients with cancer and their relatives. Heliyon. 2019 Jul;5(7):e02067.
2. Rabello LSCF, Silva JRL, Azevedo LCP, et al. Clinical Outcomes and Microbiological Characteristics of Severe Pneumonia in Cancer Patients: A Prospective Cohort Study. Efron PA, editor. PLoS ONE. 2015 Mar 24;10(3):e0120544.
3. Fine MJ, Auble TE, Yealy DM, et al. A Prediction Rule to Identify Low-Risk Patients with Community-Acquired Pneumonia. N Engl J Med. 1997 Jan 23;336(4):243–50.
4. Lim WS. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003 May 1;58(5):377–82.
5. Gonzalez C, Johnson T, Rolston K, et al. Predicting pneumonia mortality using CURB‐65, PSI, and patient characteristics in patients presenting to the emergency department of a comprehensive cancer center. Cancer Med. 2014 Aug;3(4):962–70.
6. Ahn BK, Lee Y-S, Kim Y-J, et al. Prediction model for mortality in cancer patients with pneumonia: comparison with CURB-65 and PSI. Clin Respir J. 2018 Feb;12(2):538–46.
7. ICD-10 Version:2016. Available from: https://icd.who.int/browse10/2016/en (2016, accessed 20 Mar 2022)
8. Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the Management of Adults with Community-acquired Pneumonia: Diagnosis, Assessment of Severity, Antimicrobial Therapy, and Prevention. Am J Respir Crit Care Med. 2001 Jun;163(7):1730–54.
9. This study was organised by a subcommittee of the Research Committee of the British Thoracic Society and the Public Health Laboratory Service. Community-acquired Pneumonia in Adults in British Hospitals in 1982–1983: A Survey of Aetiology, Mortality, Prognostic Factors and Outcome. QJM: An International Journal of Medicine. 1987 Mar 1;62(3):195–220.
10. Jeon K, Yoo H, Jeong B-H, et al. Functional status and mortality prediction in community-acquired pneumonia: Functional status and mortality in CAP. Respirology. 2017 Oct;22(7):1400–6.
11. Zhao W, Wang P, Jia H, et al. Lymphocyte count or percentage: which can better predict the prognosis of advanced cancer patients following palliative care? BMC Cancer. 2017 Dec;17(1):514.
12. Simmons CPL, McMillan DC, McWilliams K, et al. Prognostic Tools in Patients With Advanced Cancer: A Systematic Review. Journal of Pain and Symptom Management. 2017 May;53(5):962-970.e10.
13. Anderson F, Downing GM, Hill J, et al. Palliative Performance Scale (PPS): A New Tool. J Palliat Care. 1996 Mar;12(1):5–11.
14. Chewaskulyong B, Sapinun L, Downing GM, et al. Reliability and validity of the Thai translation (Thai PPS Adult Suandok) of the Palliative Performance Scale (PPSv2). Palliat Med. 2012 Dec;26(8):1034–41.
15. Ma C, Bandukwala S, Burman D, et al. Interconversion of three measures of performance status: An empirical analysis. European Journal of Cancer. 2010 Dec;46(18):3175–83.
16. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982 Dec;5(6):649–55.
17. de Kock I, Mirhosseini M, Lau F, et al. Conversion of Karnofsky Performance Status (Kps) and Eastern Cooperative Oncology Group Performance Status (Ecog) to Palliative Performance Scale (Pps), and the interchangeability of Pps and Kps in Prognostic Tools. J Palliat Care. 2013 Sep;29(3):163–9.
18. Hafen BB, Sharma S. Oxygen Saturation. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 [cited 2022 Mar 20]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK525974/
19. Nicholson LB. The immune system. Essays in Biochemistry. 2016 Oct 31;60(3):275–301.
20. Delves PJ, Martin SJ, Burton DR, et al. Roitt’s essential immunology. 13th edition. Chichester, West Sussex ; Hoboken, [NJ]: Wiley Blackwell; 2017. 576 p.
21. Pardoll D. Cancer and the Immune System: Basic Concepts and Targets for Intervention. Seminars in Oncology. 2015 Aug;42(4):523–38.
22. Ota Y, Ishihara S, Otani K, et al. Effect of nutrient starvation on proliferation and cytokine secretion of peripheral blood lymphocytes. Molecular and Clinical Oncology. 2016 Apr;4(4):607–10.
23. Alwarawrah Y, Kiernan K, MacIver NJ. Changes in Nutritional Status Impact Immune Cell Metabolism and Function. Front Immunol. 2018 May 16;9:1055.
24. Grossman SA, Ellsworth S, Campian J, et al. Survival in Patients With Severe Lymphopenia Following Treatment With Radiation and Chemotherapy for Newly Diagnosed Solid Tumors. J Natl Compr Canc Netw. 2015 Oct;13(10):1225–31.
25. Wang Q, Li S, Qiao S, et al. Changes in T Lymphocyte Subsets in Different Tumors Before and After Radiotherapy: A Meta-analysis. Front Immunol. 2021 Jun 16;12:648652.
26. Ugajin M, Yamaki K, Iwamura N, et al. Blood urea nitrogen to serum albumin ratio independently predicts mortality and severity of community-acquired pneumonia. IJGM. 2012 Jul;583.